BRPI0915387B8 - agente para a regeneração da membrana timpânica ou canal auditivo externo e uso de uma esponja de gelatina que carrega o fator de crescimento fibroblástico básico e uma cola de fibrina - Google Patents

agente para a regeneração da membrana timpânica ou canal auditivo externo e uso de uma esponja de gelatina que carrega o fator de crescimento fibroblástico básico e uma cola de fibrina

Info

Publication number
BRPI0915387B8
BRPI0915387B8 BRPI0915387A BRPI0915387A BRPI0915387B8 BR PI0915387 B8 BRPI0915387 B8 BR PI0915387B8 BR PI0915387 A BRPI0915387 A BR PI0915387A BR PI0915387 A BRPI0915387 A BR PI0915387A BR PI0915387 B8 BRPI0915387 B8 BR PI0915387B8
Authority
BR
Brazil
Prior art keywords
regeneration
ear canal
tympanic membrane
agent
gelatin sponge
Prior art date
Application number
BRPI0915387A
Other languages
English (en)
Inventor
Kanemaru Shin-Ichi
Original Assignee
Kaken Pharma Co Ltd
Nobelpharma Co Ltd
Shin Ichi Kanemaru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharma Co Ltd, Nobelpharma Co Ltd, Shin Ichi Kanemaru filed Critical Kaken Pharma Co Ltd
Publication of BRPI0915387A2 publication Critical patent/BRPI0915387A2/pt
Publication of BRPI0915387B1 publication Critical patent/BRPI0915387B1/pt
Publication of BRPI0915387B8 publication Critical patent/BRPI0915387B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F11/00—Methods or devices for treatment of the ears or hearing sense; Non-electric hearing aids; Methods or devices for enabling ear patients to achieve auditory perception through physiological senses other than hearing sense; Protective devices for the ears, carried on the body or in the hand
    • A61F11/20—Ear surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/14—Materials or treatment for tissue regeneration for ear reconstruction or ear implants, e.g. implantable hearing aids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymers & Plastics (AREA)
  • Prostheses (AREA)

Abstract

agente para a regeneração da membrana timpânica ou canal auditivo externo. a presente invenção refere-se a um agente de regeneração da membrana timpânica ou canal auditivo que compreende uma combinação de uma esponja de gelatina que carrega o fator de crescimento fibroblástico básico (bfgf) e um material de cobertura. o material de cobertura é utilizado não apenas para fixar a esponja de gelatina na parte afetada, mas também para o propósito de prevenir a secagem e infecções para proporcionar um ambiente de cultura que é favorável à regeneração do tecido isolado a partir da parte externa. para promover a regeneração do tecido, a margem do defeito da membrana timpânica ou canal auditivo é preferivelmente renovada antecipadamente.
BRPI0915387A 2008-06-26 2009-06-26 agente para a regeneração da membrana timpânica ou canal auditivo externo e uso de uma esponja de gelatina que carrega o fator de crescimento fibroblástico básico e uma cola de fibrina BRPI0915387B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008-167744 2008-06-26
JP2008167744 2008-06-26
PCT/JP2009/061767 WO2009157558A1 (ja) 2008-06-26 2009-06-26 鼓膜または外耳道再生剤

Publications (3)

Publication Number Publication Date
BRPI0915387A2 BRPI0915387A2 (pt) 2016-10-11
BRPI0915387B1 BRPI0915387B1 (pt) 2019-09-24
BRPI0915387B8 true BRPI0915387B8 (pt) 2021-05-25

Family

ID=41444618

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0915387A BRPI0915387B8 (pt) 2008-06-26 2009-06-26 agente para a regeneração da membrana timpânica ou canal auditivo externo e uso de uma esponja de gelatina que carrega o fator de crescimento fibroblástico básico e uma cola de fibrina

Country Status (12)

Country Link
US (3) US9161904B2 (pt)
EP (1) EP2353547B1 (pt)
JP (1) JP5398712B2 (pt)
KR (1) KR101604150B1 (pt)
CN (2) CN102131478A (pt)
AU (1) AU2009263249B2 (pt)
BR (1) BRPI0915387B8 (pt)
CA (1) CA2729093C (pt)
ES (1) ES2671068T3 (pt)
MX (1) MX2010014077A (pt)
RU (1) RU2544367C2 (pt)
WO (1) WO2009157558A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201892619A1 (ru) 2011-04-29 2019-04-30 Роше Гликарт Аг Иммуноконъюгаты, содержащие мутантные полипептиды интерлейкина-2
KR101970846B1 (ko) * 2011-07-11 2019-08-13 이어 사이언스 인스티튜트 오스트레일리아 이어 드럼 복원용 장치
DK2844309T3 (da) * 2012-06-28 2022-01-24 The Administrators Of The Tulane Educational Fund Selektivt polymeriserbare sammensætninger
AU2014265901B2 (en) * 2013-05-15 2018-11-08 The Board Of Trustees Of The Leland Stanford Junior University Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing
US11051985B2 (en) 2015-10-01 2021-07-06 Nobelpharma Co., Ltd. Preparation jig for tympanic membrane regenerating agent and preparation vessel for tympanic membrane regenerating agent
CN106693064B (zh) * 2016-12-07 2020-07-28 同济大学 一种用于上颌窦底提升的复合材料以及制备方法
CN107349471A (zh) * 2017-06-16 2017-11-17 卓阮医疗科技（苏州）有限公司 一种载药缓释的复合组织修复材料及其制备方法
JP2022043368A (ja) * 2018-12-26 2022-03-16 国立大学法人京都大学 感音難聴治療用組成物
US12390510B2 (en) * 2019-05-29 2025-08-19 Massachusetts Eye And Ear Infirmary Methods of treating sensorineural hearing loss using fibroblast growth factor 2 (FGF2)
CN110302425A (zh) * 2019-06-20 2019-10-08 温州医科大学附属第一医院 混合水凝胶生物材料的制备方法及其应用
WO2021112254A1 (ja) * 2019-12-06 2021-06-10 ノーベルファーマ株式会社 鼓膜再生用ゼラチンスポンジの製造方法
RU2763980C1 (ru) * 2021-06-04 2022-01-12 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се Способ закрытия стойких перфораций барабанной перепонки
WO2023015341A1 (en) * 2021-08-09 2023-02-16 The University Of Western Australia Compositions and methods for wound healing
CN117717650A (zh) * 2022-09-09 2024-03-19 辽宁何氏医学院 一种壳聚糖/明胶球结膜修复生物海绵及其制备方法和应用
WO2025073993A1 (en) * 2023-10-05 2025-04-10 Royal College Of Surgeons In Ireland A layered implant and system to repair a perforation in a tympanic membrane
CN118718095B (zh) * 2024-09-04 2024-11-29 诺一迈尔(山东)医学科技有限公司 一种声传导生物鼓膜修复材料及其制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS539739A (en) 1976-07-12 1978-01-28 Nippon Nohyaku Co Ltd #-trifluoromethyl-##-isoproxybenzoic acid anilide, its preparation and its use
FR2358385A1 (fr) 1976-07-12 1978-02-10 Nihon Nohyaku Co Ltd Derives de l'anilide benzoique et fongicides contenant ces derives
ATE105868T1 (de) 1985-09-12 1994-06-15 Scios Nova Inc Rekombinanter fibroblast-wachstumsfaktor.
JP2770926B2 (ja) 1985-12-17 1998-07-02 サイナーゲン インコーポレーテッド 毛管内皮細胞プロテアーゼ合成、ｄｎａ合成および遊走を促進することの出来るヒト胎盤血管形成誘導因子
JP2504468B2 (ja) 1987-06-26 1996-06-05 株式会社東芝 エレベ―タの制御装置
KR890006573A (ko) 1987-10-26 1989-06-14 메리 엔 터커 N-페닐알킬벤즈아미드 살진균제
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
JPH10337302A (ja) 1997-06-06 1998-12-22 Unitika Ltd 鼓膜欠損閉鎖促進材及びその製造方法
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
WO2001014340A1 (en) 1999-08-19 2001-03-01 Ishihara Sangyo Kaisha, Ltd. Agents for controlling animal diseases caused by endoparasites
IL149459A0 (en) * 1999-11-12 2002-11-10 Fibrogen Inc Recombinant gelatins
US20030229333A1 (en) * 2002-02-22 2003-12-11 Control Delivery Systems, Inc. Methods for treating otic disorders
EP1438942A1 (en) * 2003-01-17 2004-07-21 Schering Oy An otorhinological drug delivery device
CN1552465A (zh) * 2003-06-05 2004-12-08 胡庆柳 纤维蛋白止血贴
WO2006007417A2 (en) 2004-06-16 2006-01-19 The New York Eye & Ear Infirmary Repair of tympanic membrane perforation
WO2006062871A2 (en) 2004-12-08 2006-06-15 Pervasis Therapeutics, Inc. Materials and methods for minimally-invasive administration of a cell-containing flowable composition
RU2277423C1 (ru) 2005-04-07 2006-06-10 Андрей Валентинович Васильев Способ коррекции структурно-функциональных изменений соединительной ткани
JP2008540521A (ja) * 2005-05-12 2008-11-20 アンジオテック インターナショナル アーゲー 憩室疾患の治療のための組成物と方法
WO2007005807A2 (en) * 2005-06-30 2007-01-11 Anthrogenesis Corporation Repair of tympanic membrane using placenta derived collagen biofabric
JP5008284B2 (ja) * 2005-09-09 2012-08-22 グンゼ株式会社 組織再生用基材
JP4599563B2 (ja) 2005-11-04 2010-12-15 国立大学法人 岡山大学 外耳道再建用成形品及びその製造方法
WO2007060162A1 (en) 2005-11-22 2007-05-31 Bayer Cropscience Sa New n-(1-methyl-2phenylethyl)benzamide derivatives
TWI435863B (zh) 2006-03-20 2014-05-01 Nihon Nohyaku Co Ltd Ｎ-２-（雜）芳基乙基甲醯胺衍生物及含該衍生物之蟲害防治劑
EP2041090A1 (en) 2006-07-06 2009-04-01 Bayer CropScience SA N- (4-pyridin-2-ylbutyl) benzamide derivatives and their use as fungicides
WO2008003746A1 (en) 2006-07-06 2008-01-10 Bayer Cropscience Sa N-(4-pyridin-2-ylbutyl) carboxamide derivatives, their process of preparation and their use as fungicides
WO2008062878A1 (fr) 2006-11-22 2008-05-29 Nihon Nohyaku Co., Ltd. Nouveau dérivé de pyrazole, agent de lutte contre des organismes nuisibles et utilisation de l'agent de lutte contre des organismes nuisibles
JP5481716B2 (ja) 2006-12-13 2014-04-23 独立行政法人農業・食品産業技術総合研究機構 サイクロデキストランの製造方法およびサイクロデキストラン合成酵素の製造方法
CL2008000512A1 (es) 2007-02-22 2008-08-29 Bayer Cropscience Sa Compuestos derivados de n-(3-fenilpropil)carboxamida; procedimiento de preparacion de dichos compuestos; composicion fungicida; y metodo para combatir de forma preventiva o curativa los hongos fitopatogenos de cultivos.
CL2008000530A1 (es) 2007-02-22 2008-08-29 Bayer Cropscience Sa Compuestos derivados de n-(3-fenilpropil)benzamida; procedimiento de preparacion de dichos compuestos; composicion fungicida; y metodo para combatir de forma preventiva o curativa los hongos fitopatogenos de cultivos.
HUE029331T2 (en) 2007-04-12 2017-02-28 Nihon Nohyaku Co Ltd Worm-control agent for use in the preparation and method
WO2009012998A1 (en) 2007-07-26 2009-01-29 Syngenta Participations Ag Novel microbiocides
GB0807140D0 (en) 2008-04-18 2008-05-21 Syngenta Participations Ag Novel microbiocides
GB0904658D0 (en) 2009-03-18 2009-04-29 Syngenta Crop Protection Ag Novel microbiocides
JP2012087116A (ja) 2010-09-21 2012-05-10 Ishihara Sangyo Kaisha Ltd ベンズアミド誘導体又はその塩、それらを含有する殺虫剤、殺ダニ剤、殺線虫剤又は殺土壌害虫剤
PH12013501809A1 (en) 2011-03-02 2013-10-14 Nihon Nohyaku Co Ltd Endoparasite control agent

Also Published As

Publication number Publication date
JPWO2009157558A1 (ja) 2011-12-15
EP2353547A1 (en) 2011-08-10
US10357595B2 (en) 2019-07-23
AU2009263249B2 (en) 2015-03-19
AU2009263249A1 (en) 2009-12-30
CA2729093C (en) 2018-04-10
ES2671068T3 (es) 2018-06-04
EP2353547A4 (en) 2013-11-06
US10117969B2 (en) 2018-11-06
US20190038811A1 (en) 2019-02-07
CN105381506A (zh) 2016-03-09
CA2729093A1 (en) 2009-12-30
RU2544367C2 (ru) 2015-03-20
KR20110021994A (ko) 2011-03-04
RU2011102755A (ru) 2012-08-10
MX2010014077A (es) 2011-04-05
US20160067383A1 (en) 2016-03-10
BRPI0915387B1 (pt) 2019-09-24
JP5398712B2 (ja) 2014-01-29
US20110110987A1 (en) 2011-05-12
EP2353547B1 (en) 2018-01-17
CN102131478A (zh) 2011-07-20
KR101604150B1 (ko) 2016-03-16
BRPI0915387A2 (pt) 2016-10-11
WO2009157558A1 (ja) 2009-12-30
US9161904B2 (en) 2015-10-20

Similar Documents

Publication Publication Date Title
BRPI0915387B8 (pt) agente para a regeneração da membrana timpânica ou canal auditivo externo e uso de uma esponja de gelatina que carrega o fator de crescimento fibroblástico básico e uma cola de fibrina
CL2008001756A1 (es) Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac)
NI200900093A (es) Compuestos que modulan la actividad de c-fms y/o c-kit y uso de los mismos.
CR9942A (es) Inhibidores de proteina activadora de la 5-lipoxigenasa (flap)
BRPI0921830A8 (pt) Composição para tratamento bucal compreendendo sílica fundida
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
BRPI0610108B8 (pt) compostos promotores de apoptose e composição que compreende os ditos compostos
CL2007002635A1 (es) Compuestos derivados de quinazolinona e isoquinolinona, moduladores de la actividad del eje hpa; composicion farmaceutica que los comprende; y su uso en el tratamiento y/o prevencion relacionado con estres o depresion.
CR11731A (es) Composiciones y procedimientos para su preparación y uso
ECSP088440A (es) Imidazopirazinas como inhibidores de proteinquinasa
CR20140422A (es) Composiciones de enzima digestiva estable
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
DK1259218T3 (da) Kosmetisk sammensætning til behandling af aldrende og/eller stresset hud
AR079672A1 (es) Dilatador nasal externo mejorado
EA200801164A2 (ru) Ингибиторы протеина, активирующего 5-липоксигеназу (flap)
CL2007001698A1 (es) Composicion inmunogenica que comprende los lipooligosacaridos meningococicos (los) de inmunotipos l2 y l3 de cepas neissericas; composicion de vacuna que la comprende; procedimiento de preparacion; y su uso para la prevencion o tratamiento de enfermedades causadas por uno o mas serogrupos de n. meningitidis.
BR0114927A (pt) Composição de gel farmacêutica substancialmente não aquosa para aplicação na pele, e, uso da composição
CO6210786A2 (es) Implemento de cuidado oral que alberga un agente de cuidado oral
EP1899451A4 (en) METHOD AND COMPOSITIONS FOR REGULATING THE DEVELOPMENT OF BIOFILMS
NO20081042L (no) PPAR aktive forbindelser
MX2020003095A (es) Arni variante.
BR112012008962A2 (pt) derivados espiro-condensados de ciclohexano como inibidores de hsl úteis para o tratamento de diabetes
BR112012031626A2 (pt) composição adesiva sensível á pressão para aplicação na pele, construção adesiva com camada, e, dispositivo médico
BRPI0621277B8 (pt) aplicador de tampão
BR112017001952A2 (pt) conjunto de curativo para ferimentos

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: NOBELPHARMA CO., LTD. (JP)

B25B Requested transfer of rights rejected

Owner name: NOBELPHARMA CO., LTD. (JP)

B25B Requested transfer of rights rejected

Owner name: NOBELPHARMA CO., LTD. (JP)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/06/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF